Edwin Posadas, Md
Clinical trials sponsored by Edwin Posadas, Md, explained in plain language.
-
Can epigenetic drugs make prostate tumors more vulnerable to the immune system?
Disease control Recruiting nowThis early-stage study tests whether giving an epigenetic therapy before prostate removal surgery is safe and can help the immune system better attack the cancer. About 20 men with high-risk prostate cancer will receive the drug before their scheduled prostatectomy. The main goal…
Phase: EARLY_PHASE1 • Sponsor: Edwin Posadas, MD • Aim: Disease control
Last updated May 26, 2026 11:05 UTC
-
New combo aims to stall resistant prostate cancer
Disease control Recruiting nowThis study tests whether adding a drug called carotuximab to the standard treatment apalutamide can help men with a type of advanced prostate cancer that has stopped responding to previous therapies. About 100 participants will be enrolled to see if the combination delays cancer …
Phase: PHASE2 • Sponsor: Edwin Posadas, MD • Aim: Disease control
Last updated May 18, 2026 11:59 UTC